Amicus Therapeutics Announces Full-Year 2024 Financial Results and Corporate Updates
Provided By GlobeNewswire
Last update: Feb 19, 2025
2024 Total Revenue of $528.3M, a 33% Increase Year-over-Year
Projecting 2025 Total Revenue Growth of 17-24% at CER
Read more at globenewswire.com
